Skip to content Skip to footer

Author page: Womenpreneur Middle East Staff

Empowering Women In Web3: 4 Crypto Organizations Promoting Gender Equality

Women are underrepresented across the fintech industry, and the emerging realm of Web3 is no exception. There are many reasons for women to be both frustrated and inspired about the potential for increasing diverse representation in the crypto industry. Alarming statistics from a Boston Consulting Group study earlier this year revealed that only 13% of…

Read more

The women who shaped the Rolling Stones finally have their moment

There is a moment, several chapters into Elizabeth Winder’s “Parachute Women: Marianne Faithfull, Marsha Hunt, Bianca Jagger, Anita Pallenberg, and the Women Behind the Rolling Stones” that quietly justifies the book’s existence. In the biographical introduction of the section about aspiring R&B artist Marsha Hunt — before her life is rerouted by bearing Mick Jagger’s…

Read more

Alleged pedophile fashion mogul Peter Nygard arrested on more sexual assault charges for 1993 case

Suspected pedophile and former fashion mogul Peter Nygard was arrested on more sex crime charges, this time for a 1993 case in which he’s accused of sexually assaulting a 20-year-old at his company’s headquarters in Canada. Winnipeg, Manitoba, police obtained an arrest warrant on Monday for city native Nygard, 81, after months of investigation into…

Read more

Avante Capital Partners Changes Private Credit And Private Equity For Women

Private credit may have become a hot asset class, but it is ice-cold when it comes to inclusion. Women-owned private equity firms* account for only 7.2% of all U.S.-based firms and have a smaller share of assets under management (AUM), just 1.6%, according to the Knight Foundation. A women- and minority-owned private credit firm, Avante Capital Partners, is…

Read more

Newly approved Alzheimer’s drug may not work as well on women

Some experts are questioning whether a newly approved Alzheimer's drug was shown in clinical trials to be less effective on women — even though the FDA didn't flag any such concerns when it was authorized last week. Why it matters: Nearly two-thirds of Americans living with Alzheimer's disease are female, according to the Alzheimer's Association. The $26,500 drug, Leqembi,…

Read more